- Home
- GCV vs INCR Comparison
GCV vs INCR Comparison
Compare GCV & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- INCR
- Stock Information
- Founded
- GCV 1988
- INCR 1994
- Country
- GCV United States
- INCR Israel
- Employees
- GCV N/A
- INCR N/A
- Industry
- GCV Finance/Investors Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- GCV Finance
- INCR Health Care
- Exchange
- GCV Nasdaq
- INCR Nasdaq
- Market Cap
- GCV 79.7M
- INCR 84.5M
- IPO Year
- GCV N/A
- INCR N/A
- Fundamental
- Price
- GCV $3.99
- INCR $1.63
- Analyst Decision
- GCV
- INCR
- Analyst Count
- GCV 0
- INCR 0
- Target Price
- GCV N/A
- INCR N/A
- AVG Volume (30 Days)
- GCV 57.9K
- INCR 52.2K
- Earning Date
- GCV 01-01-0001
- INCR 08-22-2025
- Dividend Yield
- GCV 13.04%
- INCR N/A
- EPS Growth
- GCV N/A
- INCR N/A
- EPS
- GCV N/A
- INCR N/A
- Revenue
- GCV N/A
- INCR $65,575,323.00
- Revenue This Year
- GCV N/A
- INCR $69.54
- Revenue Next Year
- GCV N/A
- INCR $41.75
- P/E Ratio
- GCV N/A
- INCR N/A
- Revenue Growth
- GCV N/A
- INCR N/A
- 52 Week Low
- GCV $3.15
- INCR $1.17
- 52 Week High
- GCV $4.58
- INCR $2.30
- Technical
- Relative Strength Index (RSI)
- GCV 62.90
- INCR 57.63
- Support Level
- GCV $3.91
- INCR $1.61
- Resistance Level
- GCV $3.96
- INCR $1.77
- Average True Range (ATR)
- GCV 0.05
- INCR 0.08
- MACD
- GCV 0.00
- INCR 0.02
- Stochastic Oscillator
- GCV 84.62
- INCR 64.10
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.